Table 3.
Comparison of hepcidin and hepcidin-ferritin ratio among iron-replete individuals with and without heterozygous β-gene mutations
Normal population (N = 176) | β-thalassemia trait (N = 82) | HbE trait (N = 19) | P for difference between normal and β thalassemia trait | P for difference between normal and HbE trait | |
---|---|---|---|---|---|
Hemoglobin* | 15.2 (13.0-19.7) | 12.0 (9.6-17.6) | 13.3 (11.4-17.2) | <.001 | <.001 |
Ferritin† | 39.7 (15.5-240.7) | 39.5 (15.4-205.5) | 40.9 (17.9-94.4) | .960 | .806 |
sTfR† | 25.7 (10.4-93.2) | 35.8 (18.3-95.2) | 20.0 (11.0-32.7) | <.001 | .003 |
Serum iron* | 17.3 (2.8-33.7) | 15.7 (2.7-30.5) | 14.7 (5.7-26.1) | .036 | .071 |
Hepcidin† | 5.1 (1.2-44.6) | 4.1 (1.1-25.4) | 5.24 (4.0-6.8) | .007 | .837 |
Hepcidin-ferritin ratio† | 0.13 (0.02-0.82) | 0.10 (0.02-0.44) | 0.13 (0.05-0.69) | .011 | .997 |
Arithmetic means (range); P values calculated from Student t test between arithmetic means of normal and individuals with heterozygote β-gene mutations of interest.
Geometric means (range); P values calculated from Student t test between log-transformed means of normal and individuals with heterozygote β-gene mutations of interest.